ZUU Target Fund for SBC Medical Group HD Investment Partnership's Form 4 filing
SBC Medical Group Holdings Inc (SBC) · filed Sep 19, 2024
- Accession no.
- 0001140361-24-041498
- Filed
- Sep 19, 2024, 8:21 PM ET
- Trade date
- Sep 17-19, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $45.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| ZUU Target Fund for SBC Medical Group HD Investment PartnershipCIK 0002010768 | 10% Owner |
| ZUU Co. Ltd.CIK 0002010776 | 10% Owner |
| ZUU Funders Co. Ltd.CIK 0002010795 | 10% Owner |
| Tomita KazumasaCIK 0002010816 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | Common Stock, par value $0.0001 per share | JOtherAcquired | +1,503,473 | $0.00F1 | $0 | 2,927,191 | Indirect | |
| Sep 19, 2024 | Common Stock, par value $0.0001 per share | SSaleAcquired | +6,196 | $7.34F4 | +$45,482.36 | 2,920,995 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | Common Stock, par value $0.0001 per share | JOtherAcquired | +2,329,840 | $0.00 | $0 | 2,329,840 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a transfer of 1,503,473 shares of Common Stock pursuant to the terms of that certain Non-Redemption Agreement, dated as of January 11, 2024, among ZUU Target Fund for SBC Medical Group HD Investment Partnership (the "Fund"), SBC Medical Group Holdings Incorporated, and Yoshiyuki Aikawa, as amended.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $8.47 (inclusive) on September 19, 2024. The Reporting Persons undertake to provide to SBC Medical Group Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.